BARDA Industry DAY: Lightning Talks
APPLY NOW!
BARDA is excited to debut a new opportunity at this year’s BARDA Industry Day, to be held October 29-30, 2018 at the Grand Hyatt in Washington, DC. We will host Lightning Talks, a showcase for pharmaceutical companies, biotech and other innovators to provide an introduction to their product and approach.
ASPR’s Vision For Building Readiness: Sustaining Robust and Reliable Public Health Security Capabilities
HHS’ Vision for Healthcare Preparedness is a multi-part blog series that describes ASPR’s four pillars to achieving national health security. This blog focuses on sustaining public health security capabilities.
Apply now! DRIVe's EZ-BAA application is fast & user-friendly
We're looking for the most innovative products & technologies to protect Americans from the most serious systemic, natural and intentional health security threats. Medical product developers, research teams & companies offering disruptive solutions to health security threats are invited to submit abstracts beginning today!
Funding Opportunity Announcement: Partnership for Disaster Health Response Cooperative Agreement
ASPR released a new FOA inviting applicants to develop demonstration projects that address healthcare preparedness challenges, best practices for improving disaster readiness across the healthcare delivery system, & show the potential effectiveness & viability of a RDHRS. Full application due Aug. 15th
FDA approval of TPOXX® as a treatment for smallpox
“The Food and Drug Administration’s (FDA) approval of TPOXX® (tecovirimat) as a treatment for smallpox marks a milestone for biosecurity and a triumph against one of the most deadly diseases in history. TPOXX®, produced by SIGA Technologies, is the first – and only—FDA-approved smallpox antiviral treatment.”
|
|